2476 - 2500 of 8112 Results
Title
Year
-
OPENTitle: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD TrialJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 557End Page: 570Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212714Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212714?id=journal-of-parkinsons-disease%2Fjpd212714Citation Count: 26
-
OPENTitle: Systematic analysis of PINK1 variants of unknown significance shows intact mitophagy function for most variantsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00258-8Best OA location URL: https://www.nature.com/articles/s41531-021-00258-8.pdfCitation Count: 9
- A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in Tissue2021OPENTitle: A Comparative Study of High-Contrast Fluorescence Lifetime Probes for Imaging Amyloid in TissueJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 125Issue #: 50Start Page: 13710End Page: 13717Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jpcb.1c07762Best OA location URL: https://www.pure.ed.ac.uk/ws/files/248515310/Gorka_PAP1AmyloidFLIM_MS_Accepted.pdfCitation Count: 6
-
OPENTitle: Self-normalized Classification of Parkinson’s Disease DaTscan ImagesJournal Name: 2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/bibm52615.2021.9669820Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006242Citation Count: 2
-
RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
-
OPENTitle: Integrated Genomic, Transcriptomic and Proteomic Analysis for Identifying Markers of Alzheimer’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 11Issue #: 12Start Page: 2303End Page: 2303Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics11122303Best OA location URL: https://www.mdpi.com/2075-4418/11/12/2303/pdf?version=1638953319Citation Count: 11
-
OPENTitle: Protein Profiling of RGS6, a Pleiotropic Gene Implicated in Numerous Neuropsychiatric Disorders, Reveals Multi-Isoformic Expression and a Novel Brain-Specific IsoformJournal Name: eneuroPublisher: Society for NeuroscienceVol: 9Issue #: 1Start Page: ENEURO.0379End Page: 21.2021Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0379-21.2021Best OA location URL: https://www.eneuro.org/content/eneuro/9/1/ENEURO.0379-21.2021.full.pdfCitation Count: 9
- Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies2021OPENTitle: Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 2Start Page: 584End Page: 595Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab431Best OA location URL: https://academic.oup.com/brain/article-pdf/145/2/584/43402317/awab431.pdfCitation Count: 122
-
OPENTitle: Radiomics in predicting recurrence for patients with locally advanced breast cancer using quantitative ultrasoundJournal Name: OncotargetPublisher: Impact Journals, LLCVol: 12Issue #: 25Start Page: 2437End Page: 2448Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.18632/oncotarget.28139Best OA location URL: https://www.oncotarget.com/article/28139/pdf/Citation Count: 17
-
OPENTitle: Trait Anxiety as a Risk Factor for Impulse Control Disorders in de novo Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 2Start Page: 689End Page: 697Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212959Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212959?id=journal-of-parkinsons-disease%2Fjpd212959Citation Count: 9
- Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex2021OPENTitle: Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complexJournal Name: Molecular CellPublisher: Elsevier BVVol: 82Issue #: 1Start Page: 44End Page: 59.e6Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.molcel.2021.11.012Best OA location URL: http://www.cell.com/article/S1097276521009916/pdfCitation Count: 68
-
OPENTitle: Pathological α-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of α-syn in vivoJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 50Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.2108489118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685670Citation Count: 28
-
OPENTitle: [18F]Nifene PET/CT Imaging in Mice: Improved Methods and Preliminary Studies of α4β2* Nicotinic Acetylcholinergic Receptors in Transgenic A53T Mouse Model of α-Synucleinopathy and Post-Mortem Human Parkinson’s DiseaseJournal Name: MoleculesPublisher: MDPI AGVol: 26Issue #: 23Start Page: 7360End Page: 7360Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/molecules26237360Best OA location URL: https://www.mdpi.com/1420-3049/26/23/7360/pdf?version=1638601226Citation Count: 15
-
RESTRICTEDTitle: GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐AnalysisJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 1Start Page: 31End Page: 37Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13374Citation Count: 15
-
OPENTitle: How Parkinson’s patients in the USA perceive deep brain stimulation in the 21st century: Results of a nationwide surveyJournal Name: Journal of Clinical NeurosciencePublisher: Elsevier BVVol: 95Issue #:Start Page: 20End Page: 26Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jocn.2021.11.017Citation Count: 7
-
RESTRICTEDTitle: The Human Tic Detector: An automatic approach to tic characterization using wearable sensorsJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 134Issue #:Start Page: 102End Page: 110Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2021.10.017Citation Count: 10
-
OPENTitle: White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementiaJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 111Issue #:Start Page: 54End Page: 63Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.11.007Best OA location URL: http://escholarship.mcgill.ca/downloads/ns064b900Citation Count: 44
-
OPENTitle: Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-27204-9Best OA location URL: https://www.nature.com/articles/s41467-021-27204-9.pdfCitation Count: 35
-
OPENTitle: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 10Start Page: 1754End Page: 1764Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12505Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160203Citation Count: 7
-
RESTRICTEDTitle: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’Journal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.beCitation Count: 0
-
RESTRICTEDTitle: How to Increase Diverse Representation in Parkinson's Disease TrialsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48Citation Count: 0
-
OPENTitle: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on NeuroinflammationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 59Issue #: 2Start Page: 1140End Page: 1150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1Citation Count: 12
-
RESTRICTEDTitle: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and TreatmentJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 23Start Page: 1,17End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94Citation Count: 0
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 79